Ensign Peak Advisors’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,890
| Closed | -$43K | – | 1980 |
|
|
2022
Q3 | $43K | Buy |
1,890
+410
| +28% | +$9.33K | ﹤0.01% | 2236 |
|
|
2022
Q2 | $27K | Sell |
1,480
-45,388
| -97% | -$828K | ﹤0.01% | 2113 |
|
|
2022
Q1 | $1.25M | Hold |
46,868
| – | – | ﹤0.01% | 1079 |
|
|
2021
Q4 | $1.37M | Sell |
46,868
-148,737
| -76% | -$4.36M | ﹤0.01% | 1117 |
|
|
2021
Q3 | $12.9M | Sell |
195,605
-1,373
| -0.7% | -$90.3K | 0.03% | 386 |
|
|
2021
Q2 | $16.4M | Buy |
196,978
+13,500
| +7% | +$1.12M | 0.03% | 346 |
|
|
2021
Q1 | $14.1M | Buy |
183,478
+125,038
| +214% | +$9.59M | 0.03% | 360 |
|
|
2020
Q4 | $5.16M | Sell |
58,440
-14,192
| -20% | -$1.25M | 0.01% | 599 |
|
|
2020
Q3 | $5.36M | Buy |
72,632
+2,044
| +3% | +$151K | 0.01% | 611 |
|
|
2020
Q2 | $5.15M | Buy |
70,588
+2,936
| +4% | +$214K | 0.01% | 603 |
|
|
2020
Q1 | $3.8M | Sell |
67,652
-6,584
| -9% | -$370K | 0.01% | 593 |
|
|
2019
Q4 | $2.83M | Buy |
+74,236
| New | +$2.83M | 0.01% | 884 |
|